Investing Ideas

Investing Ideas page explains various techniques for generating sustainable income, which are helpful for experienced investors and beginners. Topics include predictions and investment strategies by famous financial personalities like Jim Rickards and Marc Chaikin.

This page covers promising income generation ideas whether you are focused on crypto assets, real estate, or equities.

It does so by concentrating on Rickards’ forecasts of gold prices and Chaikin’s Power Gauge to understand better how such gurus influence investment decisions for stable and steady earnings.

Steady Income offers the reader information on trends that affect income certainty, how to invest in inflation, and current affairs affecting income investing. The fact that many strategies are presented allows the readers to perceive higher odds and lower risk opportunities for gradually building wealth. 

The Great Barrington Project Review – Is George Gilder’s Service Legit?

The Great Barrington Project Review

George Gilder’s brand new publication – The Great Barrington Project – is where you’ll hear about the private tech companies George is most excited about. It’s your chance not just to hear about breakthrough technology companies before anyone else – but to invest alongside George as and take early stakes in the next “game-changing” tech.

Dr. David Eifrig Retirement Wake-up Call Event Review – What Is All About?

Dr. David Eifrig’s Retirement Wake-up Call Event Review

Dr. David Eifrig’s Retirement Wake-up Call Event is scheduled to take place on June 23rd when America’s No.1 retirement expert, Dr. David Eifrig is stepping forward with an urgent “wake up-call” for every American over the age of 50. He’ll share the greatest upset in the history of American retirement – and the one retirement LIE that could wipe out everything you’ve built.

Dave Lashmet Triple Play Research – Which Biotech Stocks Could Soar 100%?

Biotech Stocks Could Soar

Stansberry Venture Technology editor Dave Lashmet has spent more than two decades parsing the data to identify small-cap biotech stocks with big upside potential. And he knows that by focusing on a handful of common-sense medical and investment metrics, you can more easily tell the winners from the losers… and get in before Big Pharma catches on.